NEUROENDOCRINE REGULATION OF AGGRESSIVE BEHAVIOR

攻击性行为的神经内分泌调节

基本信息

  • 批准号:
    3440834
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1987
  • 资助国家:
    美国
  • 起止时间:
    1987-08-01 至 1989-09-30
  • 项目状态:
    已结题

项目摘要

The mechanisms through which testosterone (T) stimulates the display of male-typical aggressive behavior remain controversial. At the center of this issue is the necessity for defining the role of the androgenic and estrogenic metabolites of T in the promotion of fighting behavior. To address this fundamental question about hormone action in the central nervous system, a research strategy that integrated behavioral and biochemical studies of mice from a number of different strains was recently employed. Genotypic differences in responsiveness to the aggression-promoting property of androgen and estrogen were found among male mice from the CF-1, CFW, and CD-1 strains. These differences in sensitivity appeared to be related to genetically determined differences in receptor binding. More specifically, responsiveness to estrogen (as measured with diethylstilbestrol, DES) was related to either a higher number of binding sites or higher affinity binding between DES-estrogen receptor. The binding of DHT, an androgen that was moderately effective in promoting aggression in the 3 strains, was not systematically related to its behavioral effects. The goal of the proposed series of experiments will be to further explore the relationship between receptor binding and behavioral responsiveness through the use of integrated behavioral and biochemical investigations. The studies will determine whether the relationship between K/d, B/max, and sensitivity to the aggression-promoting property of DES can be extended to other estrogens and androgens or whether additional aspects of receptor binding (dissociation kinetics, nuclear binding) should be examined to identify the molecular correlates of behavioral responsiveness to these hormones. In addition, the role of neonatal hormonal stimulation is establishing the biochemical basis for behavioral responsiveness later in life will also be examined. The studies are expected to support the hypothesis of a relationship between receptor binding and responsiveness to the aggression-promoting property of androgen and estrogen. Such findings would significantly enhance our understanding of the molecular processes involved in the hormonal regulation of intermale aggressive behavior in mice and may facilitate the development of a theoretical model of steroid sensitivity in neural tissues that can be assessed in future investigations.
睾酮(T)刺激性激素分泌的机制 男性典型的攻击性行为的表现仍然存在争议。 这个问题的核心是有必要界定 促性腺激素的雄激素代谢产物和雌激素代谢产物 关于打斗行为的。要解决这一基本问题, 激素在中枢神经系统中的作用,一种研究策略 对小鼠的行为和生化综合研究 最近使用了许多不同的菌株。遗传型 对促进攻击性反应的差异 在雄性小鼠中发现雄激素和雌激素的特性 来自CF-1、CFW和CD-1菌株。这些差异体现在 敏感度似乎与基因决定有关 受体结合的差异。更具体地说,响应性 与雌激素(用己烯雌酚测定)有关 到更多的结合位点或更高的亲和力 DES-雌激素受体之间的结合。DHT、ANN的结合力 在促进攻击性方面适度有效的雄激素 在3个菌株中,与其行为没有系统的相关性 效果。 拟议的一系列实验的目标将是进一步 探讨受体结合与行为的关系 通过使用集成的行为和 生化调查。这些研究将确定是否 K/d、B/max与灵敏度之间的关系 DES的攻击性可以推广到其他 雌激素和雄激素还是受体的附加方面 应检查结合(解离动力学、核结合) 确定行为反应的分子相关性 这些荷尔蒙。此外,新生儿荷尔蒙的作用 刺激是建立行为的生物化学基础 在以后的生活中,我们也将考察他们的反应能力。 预计这些研究将支持这样一种假设: 受体结合与血管紧张素转换酶反应的关系 雄激素和雌激素的促攻击性。是这样的 这些发现将极大地增强我们对 参与激素调节的分子过程 小鼠的雄性间攻击行为,并可能促进 神经内分泌激素敏感性理论模型的建立 可以在未来的研究中评估的组织。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An assessment of agonist/antagonist effects of tamoxifen in the female mouse brain.
评估他莫昔芬在雌性小鼠大脑中的激动剂/拮抗剂作用。
  • DOI:
    10.1016/0018-506x(92)90020-v
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    McKenna,SE;Simon,NG;Cologer-Clifford,A
  • 通讯作者:
    Cologer-Clifford,A
Medroxyprogesterone acetate and tamoxifen do not decrease aggressive behavior in CF-1 male mice.
醋酸甲羟孕酮和他莫昔芬不会减少 CF-1 雄性小鼠的攻击行为。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NEAL G SIMON其他文献

NEAL G SIMON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NEAL G SIMON', 18)}}的其他基金

Treating Self-Abuse in Autism and Mental Retardation
治疗自闭症和智力低下的自虐
  • 批准号:
    6603570
  • 财政年份:
    2002
  • 资助金额:
    $ 5万
  • 项目类别:
A New Drug for Depression
治疗抑郁症的新药
  • 批准号:
    6444275
  • 财政年份:
    2002
  • 资助金额:
    $ 5万
  • 项目类别:
Treating Self-Abuse in Autism and Mental Retardation
治疗自闭症和智力低下的自虐
  • 批准号:
    6485783
  • 财政年份:
    2002
  • 资助金额:
    $ 5万
  • 项目类别:
DHEA: A NEUROSTEROID MODULATING AGGRESSION
DHEA:调节攻击性的神经类固醇
  • 批准号:
    6646480
  • 财政年份:
    2000
  • 资助金额:
    $ 5万
  • 项目类别:
DHEA--A NEUROSTEROID MODULATING AGGRESSION
DHEA——调节攻击性的神经类固醇
  • 批准号:
    6196354
  • 财政年份:
    2000
  • 资助金额:
    $ 5万
  • 项目类别:
DEHYDROEPIANDROSTERONE--A NEUROSTEROID MODULATING AGGRES
去氢雄甾酮——一种神经类固醇调节剂
  • 批准号:
    6392606
  • 财政年份:
    2000
  • 资助金额:
    $ 5万
  • 项目类别:
TREATING SELF-ABUSE IN AUTISM AND MENTAL RETARDATION
治疗自闭症和智力低下的自虐行为
  • 批准号:
    2776073
  • 财政年份:
    2000
  • 资助金额:
    $ 5万
  • 项目类别:
DEHYDROEPIANDROSTERONE--A NEUROSTEROID MODULATING AGGRES
去氢雄甾酮——一种神经类固醇调节剂
  • 批准号:
    6528529
  • 财政年份:
    2000
  • 资助金额:
    $ 5万
  • 项目类别:
HORMONES, NEUROTRANSMITTERS, AND BEHAVIOR
激素、神经递质和行为
  • 批准号:
    2204392
  • 财政年份:
    1994
  • 资助金额:
    $ 5万
  • 项目类别:
GENES, PROGESTINS, AND FEMALE REPRODUCTIVE BEHAVIOR
基因、孕激素和女性生殖行为
  • 批准号:
    3428397
  • 财政年份:
    1986
  • 资助金额:
    $ 5万
  • 项目类别:

相似海外基金

Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
  • 批准号:
    10930196
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
  • 批准号:
    10735807
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Sexual Differentiation of the Brain and Behaviour: Central and Peripheral Targets of Androgens
大脑和行为的性别分化:雄激素的中枢和外周目标
  • 批准号:
    RGPIN-2019-04999
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Discovery Grants Program - Individual
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
  • 批准号:
    10418461
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
  • 批准号:
    10570208
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
  • 批准号:
    10355174
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
  • 批准号:
    10688086
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Defining the impact of androgens on uterine immune cell function during endometrial tissue repair
确定子宫内膜组织修复过程中雄激素对子宫免疫细胞功能的影响
  • 批准号:
    2744296
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Studentship
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
  • 批准号:
    10431620
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
  • 批准号:
    10525097
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了